Lyme and Co-Infection Nosode

Product NDC

58048-0004

11-digit product format

580480004

Labeler code

58048

Product ID

58048-0004_0fdfd134-6049-4a2d-8a4d-447c8b570803

Type

HUMAN OTC DRUG

Nonproprietary name

Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Chlamydia Trachomatis, Babesia Microti, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Prowazekii, Encephalitis Nosode, Ledum Palustre

Dosage form

LIQUID

Route

ORAL

Labeler

Bhp Holdings, Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2019-01-29

Marketing end

2024-03-07

Substance

ANGELICA ARCHANGELICA ROOT; ANHYDROUS CITRIC ACID; ARNICA MONTANA; BABESIA MICROTI; BORRELIA BURGDORFERI; CAUSTICUM; CHLAMYDIA TRACHOMATIS; GOLDENSEAL; HUMAN HERPESVIRUS 5; JAPANESE ENCEPHALITIS VIRUS; LATRODECTUS MACTANS; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OXALIC ACID; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; RICKETTSIA PROWAZEKII; SUS SCROFA CARTILAGE; TOXICODENDRON PUBESCENS LEAF; YUCCA FILAMENTOSA

Active strength

2 [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

Pharmacologic classes

Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

NDC exclude flag

No

Listing certified through

0000-00-00

Current FDA listing

Historical FDA.report record